Ligand Pharmaceuticals Incorporated (LGND)
USD 96.67
(-2.76%)
USD 96.67
(-2.76%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 119.75 Million USD | -16.5% |
| 2022 | 143.41 Million USD | -33.28% |
| 2021 | 214.95 Million USD | 37.79% |
| 2020 | 156 Million USD | 43.2% |
| 2019 | 108.93 Million USD | -55.56% |
| 2018 | 245.11 Million USD | 80.58% |
| 2017 | 135.73 Million USD | 31.27% |
| 2016 | 103.4 Million USD | 56.42% |
| 2015 | 66.1 Million USD | 19.32% |
| 2014 | 55.4 Million USD | 28.12% |
| 2013 | 43.24 Million USD | 55.62% |
| 2012 | 27.78 Million USD | 10.58% |
| 2011 | 25.12 Million USD | 6.76% |
| 2010 | 23.53 Million USD | -0.7% |
| 2009 | 23.7 Million USD | -13.22% |
| 2008 | 27.31 Million USD | 111.84% |
| 2007 | 12.89 Million USD | -89.1% |
| 2006 | 118.31 Million USD | -13.49% |
| 2005 | 136.76 Million USD | 10.55% |
| 2004 | 123.7 Million USD | 12.95% |
| 2003 | 109.52 Million USD | 43.48% |
| 2002 | 76.33 Million USD | 22.34% |
| 2001 | 62.39 Million USD | 34.2% |
| 2000 | 46.49 Million USD | 22.99% |
| 1999 | 37.8 Million USD | 48.82% |
| 1998 | 25.4 Million USD | -58.7% |
| 1997 | 61.5 Million USD | 33.12% |
| 1996 | 46.2 Million USD | 63.83% |
| 1995 | 28.2 Million USD | 347.37% |
| 1994 | -11.4 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 30.36 Million USD | 52.53% |
| 2024 Q1 | 19.91 Million USD | -24.69% |
| 2023 Q1 | 40.26 Million USD | 39.95% |
| 2023 Q2 | 24.69 Million USD | -38.66% |
| 2023 FY | 119.75 Million USD | -16.5% |
| 2023 Q4 | 26.43 Million USD | -10.03% |
| 2023 Q3 | 29.38 Million USD | 18.97% |
| 2022 Q4 | 28.76 Million USD | -44.61% |
| 2022 Q1 | 40.99 Million USD | -32.23% |
| 2022 FY | 143.41 Million USD | -33.28% |
| 2022 Q3 | 51.93 Million USD | 15.26% |
| 2022 Q2 | 45.05 Million USD | 9.91% |
| 2021 Q2 | 54.08 Million USD | 15.08% |
| 2021 Q4 | 60.48 Million USD | 13.3% |
| 2021 FY | 214.95 Million USD | 37.79% |
| 2021 Q1 | 46.99 Million USD | -19.32% |
| 2021 Q3 | 53.38 Million USD | -1.28% |
| 2020 FY | 156 Million USD | 43.2% |
| 2020 Q1 | 28.47 Million USD | 13.61% |
| 2020 Q2 | 33.77 Million USD | 18.6% |
| 2020 Q3 | 35.49 Million USD | 5.09% |
| 2020 Q4 | 58.25 Million USD | 64.11% |
| 2019 FY | 108.93 Million USD | -55.56% |
| 2019 Q1 | 39.62 Million USD | -30.03% |
| 2019 Q2 | 22.58 Million USD | -43.01% |
| 2019 Q3 | 21.66 Million USD | -4.08% |
| 2019 Q4 | 25.06 Million USD | 15.72% |
| 2018 Q3 | 44.2 Million USD | -50.28% |
| 2018 Q2 | 88.9 Million USD | 60.58% |
| 2018 Q1 | 55.36 Million USD | 13.63% |
| 2018 Q4 | 56.63 Million USD | 28.12% |
| 2018 FY | 245.11 Million USD | 80.58% |
| 2017 Q2 | 27.09 Million USD | -6.34% |
| 2017 Q3 | 30.99 Million USD | 14.39% |
| 2017 FY | 135.73 Million USD | 31.27% |
| 2017 Q1 | 28.92 Million USD | -18.03% |
| 2017 Q4 | 48.72 Million USD | 57.23% |
| 2016 Q3 | 20.62 Million USD | 9.68% |
| 2016 FY | 103.4 Million USD | 56.42% |
| 2016 Q4 | 35.28 Million USD | 71.14% |
| 2016 Q2 | 18.8 Million USD | -34.48% |
| 2016 Q1 | 28.69 Million USD | 41.29% |
| 2015 Q2 | 15.81 Million USD | 16.93% |
| 2015 Q3 | 16.45 Million USD | 4.0% |
| 2015 FY | 66.1 Million USD | 19.32% |
| 2015 Q4 | 20.3 Million USD | 23.45% |
| 2015 Q1 | 13.52 Million USD | -28.79% |
| 2014 FY | 55.4 Million USD | 28.12% |
| 2014 Q3 | 13.47 Million USD | 43.04% |
| 2014 Q1 | 13.5 Million USD | 0.65% |
| 2014 Q4 | 18.99 Million USD | 40.95% |
| 2014 Q2 | 9.42 Million USD | -30.24% |
| 2013 FY | 43.24 Million USD | 55.62% |
| 2013 Q3 | 10.46 Million USD | 25.11% |
| 2013 Q4 | 13.42 Million USD | 28.21% |
| 2013 Q2 | 8.36 Million USD | -23.86% |
| 2013 Q1 | 10.98 Million USD | -2.82% |
| 2012 Q2 | 5.3 Million USD | -3.17% |
| 2012 FY | 27.78 Million USD | 10.58% |
| 2012 Q1 | 5.48 Million USD | -49.61% |
| 2012 Q4 | 11.3 Million USD | 98.65% |
| 2012 Q3 | 5.69 Million USD | 7.25% |
| 2011 Q4 | 10.87 Million USD | 115.92% |
| 2011 Q1 | 3.37 Million USD | -14.44% |
| 2011 Q2 | 5.84 Million USD | 73.24% |
| 2011 FY | 25.12 Million USD | 6.76% |
| 2011 Q3 | 5.03 Million USD | -13.73% |
| 2010 Q1 | 5.95 Million USD | -79.6% |
| 2010 FY | 23.53 Million USD | -0.7% |
| 2010 Q4 | 3.94 Million USD | -49.5% |
| 2010 Q2 | 5.83 Million USD | -2.01% |
| 2010 Q3 | 7.8 Million USD | 33.64% |
| 2009 Q3 | -7.33 Million USD | -196.58% |
| 2009 Q4 | 29.21 Million USD | 498.31% |
| 2009 Q2 | 7.59 Million USD | -19.81% |
| 2009 Q1 | 9.47 Million USD | -23.56% |
| 2009 FY | 23.7 Million USD | -13.22% |
| 2008 Q3 | 5.24 Million USD | 9.24% |
| 2008 FY | 27.31 Million USD | 111.84% |
| 2008 Q1 | 4.87 Million USD | -15.53% |
| 2008 Q4 | 12.38 Million USD | 136.07% |
| 2008 Q2 | 4.8 Million USD | -1.44% |
| 2007 FY | 12.89 Million USD | -89.1% |
| 2007 Q3 | 5.47 Million USD | 288.58% |
| 2007 Q2 | 1.41 Million USD | 500.0% |
| 2007 Q1 | 235 Thousand USD | -99.17% |
| 2007 Q4 | 5.77 Million USD | 5.31% |
| 2006 Q4 | 28.25 Million USD | -8.58% |
| 2006 FY | 118.31 Million USD | -13.49% |
| 2006 Q3 | 30.9 Million USD | -19.05% |
| 2006 Q1 | 41.21 Million USD | 1.12% |
| 2006 Q2 | 38.18 Million USD | -7.36% |
| 2005 Q2 | 35.13 Million USD | 35.54% |
| 2005 FY | 136.76 Million USD | 10.55% |
| 2005 Q3 | 32.77 Million USD | -6.7% |
| 2005 Q4 | 40.76 Million USD | 24.36% |
| 2005 Q1 | 25.92 Million USD | -3.64% |
| 2004 Q4 | 26.89 Million USD | -30.11% |
| 2004 Q3 | 38.48 Million USD | 26.04% |
| 2004 Q2 | 30.53 Million USD | 9.88% |
| 2004 Q1 | 27.78 Million USD | -43.22% |
| 2004 FY | 123.7 Million USD | 12.95% |
| 2003 Q4 | 48.94 Million USD | 115.43% |
| 2003 Q1 | 16.5 Million USD | -24.31% |
| 2003 FY | 109.52 Million USD | 43.48% |
| 2003 Q2 | 21.36 Million USD | 29.43% |
| 2003 Q3 | 22.71 Million USD | 6.36% |
| 2002 Q2 | 14.48 Million USD | -29.09% |
| 2002 Q4 | 21.8 Million USD | 11.13% |
| 2002 FY | 76.33 Million USD | 22.34% |
| 2002 Q1 | 20.42 Million USD | 11.88% |
| 2002 Q3 | 19.62 Million USD | 35.45% |
| 2001 Q1 | 15.13 Million USD | 163.95% |
| 2001 Q4 | 18.25 Million USD | 17.57% |
| 2001 Q3 | 15.52 Million USD | 1.17% |
| 2001 FY | 62.39 Million USD | 34.2% |
| 2001 Q2 | 15.34 Million USD | 1.43% |
| 2000 Q2 | 12.78 Million USD | -8.74% |
| 2000 Q4 | 5.73 Million USD | -58.93% |
| 2000 Q3 | 13.95 Million USD | 9.15% |
| 2000 FY | 46.49 Million USD | 22.99% |
| 2000 Q1 | 14.01 Million USD | 103.07% |
| 1999 Q2 | 9.4 Million USD | -12.96% |
| 1999 Q3 | 10.7 Million USD | 13.83% |
| 1999 FY | 37.8 Million USD | 48.82% |
| 1999 Q1 | 10.8 Million USD | 63.64% |
| 1999 Q4 | 6.9 Million USD | -35.51% |
| 1998 Q1 | 6.9 Million USD | -71.84% |
| 1998 FY | 25.4 Million USD | -58.7% |
| 1998 Q4 | 6.6 Million USD | 15.79% |
| 1998 Q3 | 5.7 Million USD | -8.06% |
| 1998 Q2 | 6.2 Million USD | -10.14% |
| 1997 Q3 | 12.7 Million USD | 4.1% |
| 1997 Q4 | 24.5 Million USD | 92.91% |
| 1997 FY | 61.5 Million USD | 33.12% |
| 1997 Q1 | 12.1 Million USD | 0.0% |
| 1997 Q2 | 12.2 Million USD | 0.83% |
| 1996 FY | 46.2 Million USD | 63.83% |
| 1996 Q1 | 9.9 Million USD | 8.79% |
| 1996 Q2 | 9.7 Million USD | -2.02% |
| 1996 Q3 | 14.7 Million USD | 51.55% |
| 1996 Q4 | 12.1 Million USD | -17.69% |
| 1995 FY | 28.2 Million USD | 347.37% |
| 1995 Q1 | 5.3 Million USD | 478.57% |
| 1995 Q4 | 9.1 Million USD | 21.33% |
| 1995 Q3 | 7.5 Million USD | 38.89% |
| 1995 Q2 | 5.4 Million USD | 1.89% |
| 1994 Q2 | -3.7 Million USD | -2.78% |
| 1994 FY | -11.4 Million USD | 0.0% |
| 1994 Q3 | -2.7 Million USD | 27.03% |
| 1994 Q4 | -1.4 Million USD | 48.15% |
| 1994 Q1 | -3.6 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | 120.47 Million USD | 0.598% |
| Jaguar Health, Inc. | 7.72 Million USD | -1450.401% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 18135.09% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 2395160.0% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 92.111% |
| ContextLogic Inc. | 59 Million USD | -102.971% |
| MiMedx Group, Inc. | 266.84 Million USD | 55.122% |
| MEI Pharma, Inc. | 49.32 Million USD | -142.774% |
| AlloVir, Inc. | -398 Thousand USD | 30188.693% |
| Novavax, Inc. | 639.93 Million USD | 81.287% |
| Aptorum Group Limited | -1.11 Million USD | 10843.186% |
| Ardelyx, Inc. | 106.66 Million USD | -12.274% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 50.255% |
| Psyence Biomedical Ltd. | -240.00 USD | 49897183.333% |
| Vaxcyte, Inc. | -75 Million USD | 259.671% |
| Precigen, Inc. | 106 Thousand USD | -112874.528% |
| Pharming Group N.V. | 220.1 Million USD | 45.593% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -23153.01% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -11768.484% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | -9.092% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 166.013% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 23274.442% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bicycle Therapeutics plc | -129.52 Million USD | 192.459% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 364.21% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 644.654% |
| Acelyrin, Inc. | -115 Thousand USD | 104233.043% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 21072.504% |
| Senti Biosciences, Inc. | -2.68 Million USD | 4563.399% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -2856.134% |
| AbCellera Biologics Inc. | 38.02 Million USD | -214.932% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 2595.894% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -99694.167% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -311.113% |
| Chimerix, Inc. | 324 Thousand USD | -36860.802% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -24043.75% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 146140.244% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 484.222% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 24440.041% |
| Elevation Oncology, Inc. | -39 Thousand USD | 307158.974% |
| Alkermes plc | 1.37 Billion USD | 91.289% |
| Fortress Biotech, Inc. | 57.85 Million USD | -106.995% |
| Fortress Biotech, Inc. | 57.85 Million USD | -106.995% |
| Agenus Inc. | 139.61 Million USD | 14.226% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -622.405% |
| Dyadic International, Inc. | 922.95 Thousand USD | -12874.927% |
| ImmuCell Corporation | 4.39 Million USD | -2623.96% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -468.601% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 212.844% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 68591.733% |
| Immix Biopharma, Inc. | -5468.00 USD | 2190169.495% |
| Incyte Corporation | 3.44 Billion USD | 96.519% |
| IO Biotech, Inc. | -756 Thousand USD | 15940.344% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 355.669% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 996.499% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 271107.966% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 221.927% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 217832.727% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -14831.796% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 22823.529% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -307.503% |
| NextCure, Inc. | -3.68 Million USD | 3350.624% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -528.856% |
| Onconetix, Inc. | -1.12 Million USD | 10724.265% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 513.398% |
| Opthea Limited | 21.72 Thousand USD | -551248.987% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 208998.231% |
| PureTech Health plc | -1.6 Million USD | 7570.555% |
| Pyxis Oncology, Inc. | -2 Million USD | 6087.65% |
| Seer, Inc. | 7.02 Million USD | -1604.184% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 1191553.587% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -1421.446% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 3137.837% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -28143.632% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -15.038% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 11.47% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 223.52% |
| ChromaDex Corporation | 50.78 Million USD | -135.827% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 51717.672% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 254.325% |
| CRISPR Therapeutics AG | 240.95 Million USD | 50.301% |
| Precision BioSciences, Inc. | 40.47 Million USD | -195.891% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 221.994% |
| Innoviva, Inc. | 261.06 Million USD | 54.129% |
| Summit Therapeutics Inc. | -2.05 Million USD | 5941.61% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -2635.336% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -455.827% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 101165.06% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 83667.456% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -19563.875% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 61.822% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -4552.409% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 236113.007% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 1787.137% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 25335.331% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 1151571.154% |
| Soligenix, Inc. | 97.31 Thousand USD | -122962.141% |
| Century Therapeutics, Inc. | -10.8 Million USD | 1207.901% |
| Kura Oncology, Inc. | -849 Thousand USD | 14205.183% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 278.459% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 81564.626% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -20.915% |
| Autolus Therapeutics plc | -4.86 Million USD | 2560.51% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -189.356% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 71381.548% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -26.424% |
| GRI Bio, Inc. | 10.84 Million USD | -1004.631% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -4614.711% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 1478.531% |
| IGM Biosciences, Inc. | -211.66 Million USD | 156.578% |
| INmune Bio, Inc. | 155 Thousand USD | -77160.0% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -93.34% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 8050.19% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 18567.463% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 409176.313% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -29689.303% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 6099.649% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 38359.744% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -26.775% |
| Verastem, Inc. | -62 Thousand USD | 193250.0% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -4817.988% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 45982.375% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -3856.161% |
| Histogen Inc. | 3.76 Million USD | -3077.315% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -20683.992% |
| Surrozen, Inc. | -27.23 Million USD | 539.783% |
| Organovo Holdings, Inc. | -5.38 Million USD | 2322.175% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 10038.998% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 566.928% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -497.212% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 6048231.313% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -1874.03% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 178487.034% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 22.636% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -82035.117% |
| Apollomics, Inc. | 127 Thousand USD | -94193.701% |
| Amarin Corporation plc | 165.54 Million USD | 27.66% |
| Mesoblast Limited | -9.81 Million USD | 1320.102% |
| Turnstone Biologics Corp. | 16.5 Million USD | -625.512% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 208.385% |
| Synaptogenix, Inc. | -6347.00 USD | 1886865.401% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 234909.804% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 25.788% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 93.187% |
| Better Therapeutics, Inc. | -2.72 Million USD | 4488.164% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 206.769% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 64.579% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 1049828.261% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 2012.987% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 10908.032% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -1536.417% |
| Insmed Incorporated | 239.63 Million USD | 50.027% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -3246.926% |
| OmniAb, Inc. | 14.66 Million USD | -716.479% |
| Alector, Inc. | -95.05 Million USD | 225.986% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 4.671% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 375.529% |
| Zai Lab Limited | 170.9 Million USD | 29.929% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -46.26% |
| Aura Biosciences, Inc. | -1.29 Million USD | 9347.336% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -92017.692% |
| Immunic, Inc. | -111 Thousand USD | 107985.586% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -655.349% |
| Veracyte, Inc. | 248.14 Million USD | 51.741% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 101.713% |
| FibroGen, Inc. | 128.9 Million USD | 7.099% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 21232901.418% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 1126.435% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 96.476% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -30684.833% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 66.3% |
| TG Therapeutics, Inc. | 219.1 Million USD | 45.345% |
| Galecto, Inc. | -830 Thousand USD | 14528.072% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 8746.426% |
| Fortrea Holdings Inc. | 424 Million USD | 71.756% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 238.978% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 21220.459% |
| XBiotech Inc. | -1.74 Million USD | 6966.571% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 10908.032% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 357.694% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 258.542% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -63.145% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -612.688% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 69.218% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 341.209% |
| Vaxxinity, Inc. | -2.23 Million USD | 5460.474% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 63.35% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 1157.53% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -389.767% |
| NexImmune, Inc. | -1.02 Million USD | 11783.539% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -2217548.148% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 1785.319% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 98.94% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 179298.528% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 3472.374% |
| Ainos, Inc. | -253.73 Thousand USD | 47296.462% |
| Pluri Inc. | 322 Thousand USD | -37090.373% |
| Prothena Corporation plc | -129.2 Million USD | 192.687% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -137.492% |
| Celularity Inc. | 6.75 Million USD | -1672.805% |
| Rallybio Corporation | -150 Thousand USD | 79935.333% |
| Cue Biopharma, Inc. | -32.6 Million USD | 467.262% |
| MeiraGTx Holdings plc | 287 Thousand USD | -41625.784% |
| Omeros Corporation | -69.77 Million USD | 271.618% |
| Humacyte, Inc. | -76.55 Million USD | 256.438% |
| Immunocore Holdings plc | 248.39 Million USD | 51.789% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 889.459% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -91.967% |
| Blueprint Medicines Corporation | 236.58 Million USD | 49.382% |
| CalciMedica, Inc. | -58 Thousand USD | 206570.69% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 8497.826% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -312.16% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 4310.724% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 487.99% |
| Pulmatrix, Inc. | -8.22 Million USD | 1556.849% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 10335.299% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 30113.283% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 130.029% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -4214.514% |
| Cytokinetics, Incorporated | -322.59 Million USD | 137.122% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -13790.767% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 35218.182% |
| Vor Biopharma Inc. | -3.49 Million USD | 3529.353% |
| Roivant Sciences Ltd. | 109.23 Million USD | -9.629% |
| Evogene Ltd. | 1.39 Million USD | -8459.9% |
| ProKidney Corp. | -3.16 Million USD | 3878.889% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 372.711% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -1646.434% |
| CorMedix Inc. | -205.56 Thousand USD | 58356.39% |
| BioLineRx Ltd. | 1.1 Million USD | -10708.032% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 252.22% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 362987.879% |
| Atai Life Sciences N.V. | -5000.00 USD | 2395160.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 98371.773% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 124842.708% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 8721.526% |
| Sagimet Biosciences Inc. | 2 Million USD | -5887.65% |
| MediciNova, Inc. | 979.7 Thousand USD | -12123.373% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 242.024% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 126749.04% |
| GeoVax Labs, Inc. | -20.72 Million USD | 677.937% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 51.028% |
| Biomea Fusion, Inc. | -4.2 Million USD | 2950.583% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 86.272% |
| Mereo BioPharma Group plc | 7.42 Million USD | -1512.618% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 38730.0% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 998041.667% |
| Absci Corporation | -41.84 Million USD | 386.155% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 2395160.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 256.8% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 4966.03% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 43.971% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 12826.142% |
| Allakos Inc. | -6.14 Million USD | 2050.057% |
| Imunon, Inc. | -720 Thousand USD | 16732.246% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 273.565% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 74.836% |
| BioAtla, Inc. | -103.73 Million USD | 215.446% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 1049828.261% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 67376.966% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 149.318% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 38605.788% |
| XOMA Corporation | 3.86 Million USD | -3001.606% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 270.868% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -709.47% |
| aTyr Pharma, Inc. | -2.38 Million USD | 5114.782% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -861.1% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 413041.379% |
| Viridian Therapeutics, Inc. | -1 Million USD | 11980.258% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -921176823.077% |
| Akari Therapeutics, Plc | -4000.00 USD | 2993925.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 81.197% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -61403.893% |
| UroGen Pharma Ltd. | 73.35 Million USD | -63.258% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 548.614% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -1031364.255% |
| Orgenesis Inc. | -5.72 Million USD | 2191.755% |
| Entera Bio Ltd. | -56 Thousand USD | 213944.643% |
| GH Research PLC | -315 Thousand USD | 38116.825% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 63461.376% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 22910.095% |
| Xencor, Inc. | -85.26 Million USD | 240.456% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 54292.518% |
| Replimune Group, Inc. | -2.65 Million USD | 4610.471% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 12060.517% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 32.664% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -61403.893% |
| Portage Biotech Inc. | -54 Thousand USD | 221864.815% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 126749.04% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 31864.721% |
| OncoCyte Corporation | 413 Thousand USD | -28895.884% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 2664237.931% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 53942892.793% |
| Purple Biotech Ltd. | -196 Thousand USD | 61198.469% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -1235.337% |
| scPharmaceuticals Inc. | 9.78 Million USD | -1124.218% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 1246.515% |
| HilleVax, Inc. | -2.15 Million USD | 5654.406% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 123556.701% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 798240.496% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 18027.096% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 520765.217% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 1595496.314% |
| Savara Inc. | -44.26 Million USD | 370.555% |
| Curis, Inc. | 9.81 Million USD | -1120.599% |
| Daré Bioscience, Inc. | 2.76 Million USD | -4223.959% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 96065.157% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 7026.142% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 52623.246% |
| BeiGene, Ltd. | 2.07 Billion USD | 94.239% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 4383.165% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 129.963% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -111.249% |
| Erasca, Inc. | -3.73 Million USD | 3308.816% |
| bluebird bio, Inc. | -4.03 Million USD | 3071.538% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 424485.144% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 93.712% |
| DBV Technologies S.A. | 15.72 Million USD | -661.4% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 424485.144% |
| Moderna, Inc. | 2.15 Billion USD | 94.443% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 13187.76% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -1395.791% |
| Molecular Templates, Inc. | 50.39 Million USD | -137.629% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 22441.978% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 10.49% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 2024.671% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 404.382% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 207.761% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 3437.598% |
| MacroGenics, Inc. | 50.52 Million USD | -137.008% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 2063.808% |
| Prime Medicine, Inc. | -147.9 Million USD | 180.966% |
| Aditxt, Inc. | -111.66 Thousand USD | 107347.895% |
| Adagene Inc. | 18.11 Million USD | -561.199% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -24439.549% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 14.585% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 24.128% |
| SciSparc Ltd. | 2.19 Million USD | -5353.233% |
| Vericel Corporation | 135.57 Million USD | 11.671% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 478174.973% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 386624.434% |
| Generation Bio Co. | -73.91 Million USD | 262.023% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 27503.432% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -119.252% |
| Invivyd, Inc. | -2.02 Million USD | 6004.98% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 139.806% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 115872.733% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -24.266% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -21.839% |
| ADMA Biologics, Inc. | 88.21 Million USD | -35.747% |
| Clene Inc. | 533 Thousand USD | -22367.73% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -396.711% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 12613.375% |
| GeoVax Labs, Inc. | -20.72 Million USD | 677.937% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -5923.793% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 61727.967% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -140.444% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 1788.565% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 14424.522% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -43.563% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -163693.905% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -125.261% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 169.146% |
| Trevena, Inc. | 1.45 Million USD | -8130.447% |
| Surrozen, Inc. | -27.23 Million USD | 539.783% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 34024.363% |
| Cingulate Inc. | -582.91 Thousand USD | 20643.713% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 386400.0% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 707.914% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 1582041.876% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 13692.849% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 82.408% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 12220.749% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 212646.59% |
| Kronos Bio, Inc. | 1.37 Million USD | -8628.353% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 323.145% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 41111.301% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 24623.77% |
| ImmunityBio, Inc. | -17.89 Million USD | 769.385% |
| Korro Bio, Inc. | -3.63 Million USD | 3398.981% |
| Kineta, Inc. | 5.43 Million USD | -2104.178% |
| BioVie Inc. | -229.37 Thousand USD | 52307.937% |
| Codexis, Inc. | 57.33 Million USD | -108.869% |
| Celularity Inc. | 6.75 Million USD | -1672.805% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -2884.127% |
| Celcuity Inc. | -142.77 Thousand USD | 83977.091% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -236612.789% |
| Cibus, Inc. | 1.42 Million USD | -8321.449% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 32119.519% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 622.505% |
| IN8bio, Inc. | -2.5 Million USD | 4888.205% |
| Kodiak Sciences Inc. | -25.94 Million USD | 561.529% |
| Annexon, Inc. | -3.26 Million USD | 3765.534% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 5958.757% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 386.923% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -18611.406% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 84.618% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 30.761% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 6402.789% |
| Arcellx, Inc. | 108.27 Million USD | -10.597% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 469.962% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -51.196% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 666.155% |
| Moolec Science SA | -143.3 Thousand USD | 83665.123% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 382.984% |
| Geron Corporation | -123.5 Million USD | 196.964% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -3543.231% |
| Royalty Pharma plc | 1.79 Billion USD | 93.324% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 270.856% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 3315520.819% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -51653.525% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 207.485% |
| Humacyte, Inc. | -76.55 Million USD | 256.438% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 12716.549% |
| 89bio, Inc. | -273 Thousand USD | 43965.568% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 9626.889% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 14221.816% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 97460.163% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -10601.787% |
| Notable Labs, Ltd. | 113 Thousand USD | -105876.106% |
| Liquidia Corporation | 14.6 Million USD | -720.226% |
| Mustang Bio, Inc. | -2.22 Million USD | 5482.157% |
| Immunovant, Inc. | -231 Thousand USD | 51941.126% |
| Quantum-Si incorporated | 488 Thousand USD | -24439.549% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 315.542% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 399276.667% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -6331.418% |
| Acasti Pharma Inc. | -11 Thousand USD | 1088763.636% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 58625.44% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 18567.463% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 171.489% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -10454.831% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 31531.234% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 6216.088% |
| PepGen Inc. | -1.18 Million USD | 10214.274% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 94393.701% |
| United Therapeutics Corporation | 2.07 Billion USD | 94.215% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 623.007% |
| Solid Biosciences Inc. | -76.56 Million USD | 256.411% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 145109.263% |
| Immuneering Corporation | -764.13 Thousand USD | 15771.646% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -180621.055% |
| Belite Bio, Inc | -399 Thousand USD | 30113.283% |
| XOMA Corporation | 3.86 Million USD | -3001.606% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 697.689% |
| Bionomics Limited | -434.44 Thousand USD | 27664.34% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 11250.186% |
| uniQure N.V. | 2.21 Million USD | -5306.456% |
| Cassava Sciences, Inc. | -89.42 Million USD | 233.917% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 230.069% |
| Forte Biosciences, Inc. | -9000.00 USD | 1330688.889% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 14441.677% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 27503.432% |
| Altimmune, Inc. | -65.37 Million USD | 283.184% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 66.922% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 11250.186% |
| Compugen Ltd. | 31.45 Million USD | -280.712% |
| Peak Bio, Inc. | 367.76 Thousand USD | -32462.016% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -388.469% |
| Benitec Biopharma Inc. | 108 Thousand USD | -110782.407% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 153629.487% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 10054.53% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 6672.613% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 100732.773% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 10054.53% |
| Instil Bio, Inc. | -4.75 Million USD | 2617.935% |
| argenx SE | 1.1 Billion USD | 89.197% |
| Immunome, Inc. | -8.9 Million USD | 1444.482% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 6436.138% |
| Verona Pharma plc | -679.62 Thousand USD | 17720.478% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 68530.286% |
| Shattuck Labs, Inc. | -2.38 Million USD | 5121.09% |
| CervoMed Inc. | -1.29 Million USD | 9357.151% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 5075.197% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 2606.866% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -4746.338% |
| Moolec Science SA | -143.3 Thousand USD | 83665.123% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 29449.067% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 4582.566% |
| AnaptysBio, Inc. | 14.78 Million USD | -710.182% |
| Design Therapeutics, Inc. | -537 Thousand USD | 22400.372% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 28145.199% |
| NeurAxis, Inc. | 2.15 Million USD | -5452.593% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -5480.289% |
| Lumos Pharma, Inc. | 2 Million USD | -5866.766% |
| Achilles Therapeutics plc | -4.73 Million USD | 2631.098% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 68530.286% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 113421.978% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -278.262% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -13790.767% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 11703.973% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 362.916% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -278395.349% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 14668.491% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 910215.519% |
| Palisade Bio, Inc. | 246 Thousand USD | -48580.081% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 362987.879% |
| Beam Therapeutics Inc. | -59.67 Million USD | 300.685% |
| Neurogene Inc. | -3.26 Million USD | 3771.153% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 14.054% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 3343.581% |
| Sesen Bio, Inc. | 40 Million USD | -199.383% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 40420.875% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 3073.725% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 1351.861% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -750.518% |
| Athira Pharma, Inc. | -969 Thousand USD | 12458.411% |
| Vaccinex, Inc. | -16 Million USD | 848.269% |
| HCW Biologics Inc. | -574.82 Thousand USD | 20932.985% |
| XOMA Corporation | 3.86 Million USD | -3001.606% |
| Nektar Therapeutics | 53.47 Million USD | -123.929% |
| Arvinas, Inc. | 71.8 Million USD | -66.787% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 243.484% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 290.765% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 37290.373% |
| Rezolute, Inc. | -36 Thousand USD | 332747.222% |
| Clene Inc. | 533 Thousand USD | -22367.73% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 9326657.632% |
| BeyondSpring Inc. | 1.75 Million USD | -6739.121% |
| Synlogic, Inc. | -1.92 Million USD | 6324.168% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 323756.757% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 1991.235% |
| Peak Bio, Inc. | 367.76 Thousand USD | -32462.016% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 731.509% |
| Krystal Biotech, Inc. | 47.6 Million USD | -151.556% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 15.124% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -2283.144% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 4725.063% |
| MannKind Corporation | 136.19 Million USD | 12.07% |
| Ikena Oncology, Inc. | -50.49 Million USD | 337.172% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | -10.053% |
| Gossamer Bio, Inc. | -4.38 Million USD | 2830.969% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 47621.032% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 2395160.0% |
| Legend Biotech Corporation | 140.92 Million USD | 15.026% |
| Mural Oncology plc | -2.56 Million USD | 4765.095% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 21833.757% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 119853.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -477.012% |
| REGENXBIO Inc. | 53.02 Million USD | -125.825% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 2335.469% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 62349.773% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 7014.145% |
| Vaxart, Inc. | -60.76 Million USD | 297.082% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 45671.581% |
| Cellectis S.A. | 18 Thousand USD | -665194.444% |
| Longeveron Inc. | 221 Thousand USD | -54086.878% |
| Repare Therapeutics Inc. | -80.07 Million USD | 249.56% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 89.044% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 9354.482% |
| Revolution Medicines, Inc. | -399.66 Million USD | 129.963% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 342251.429% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -244293.878% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 98.609% |
| Denali Therapeutics Inc. | -93.34 Million USD | 228.291% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 478174.973% |
| Veru Inc. | 7.56 Million USD | -1482.793% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 79406.623% |
| Cingulate Inc. | -582.91 Thousand USD | 20643.713% |
| Passage Bio, Inc. | -3.72 Million USD | 3318.302% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 994395.915% |
| Exicure, Inc. | -1.42 Million USD | 8515.531% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 31367.102% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -4330.374% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 23458.463% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -75.782% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 80145.051% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 302.265% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -30527.366% |
| OmniAb, Inc. | 14.66 Million USD | -716.479% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -498.975% |
| Lipocine Inc. | -2.85 Million USD | 4300.654% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 6597.721% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 2199.089% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 8050.19% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -59.001% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 184335.385% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -42.062% |
| Ocugen, Inc. | -33.53 Million USD | 457.077% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 3887.255% |
| Q32 Bio Inc. | 578 Thousand USD | -20618.512% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 45289.811% |
| Alumis Inc. Common Stock | -1.28 Million USD | 9426.558% |
| Equillium, Inc. | 35.95 Million USD | -233.036% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 7115.407% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -23818.119% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 2896882.777% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 46336.68% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -28229.69% |
| Dominari Holdings Inc. | 2.03 Million USD | -5773.124% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 65370.806% |
| vTv Therapeutics Inc. | -13.59 Million USD | 980.861% |
| Bio-Techne Corporation | 773.07 Million USD | 84.51% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -591.454% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 74.011% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 10344.055% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 599.387% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -923.792% |
| Nkarta, Inc. | -5.86 Million USD | 2140.433% |
| BioCardia, Inc. | -7.24 Million USD | 1751.993% |
| Iterum Therapeutics plc | -1.75 Million USD | 6943.029% |